Ivy Ku is a Cardiology physician affiliated with Kaiser Permanente. OpenAlex indexes 56 publications with 1,166 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2200 Ofarrell St
4th Floor
San Francisco, CA 941153357
Telephone
415-833-2616Registry record last updated 15 Dec 2021.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202510 payments
- Abbott LaboratoriesProgram year20258 payments
- Boston Scientific CorporationProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
93.7%Beta blocker25.8%Metoprolol Succinate39%Carvedilol34%Metoprolol Tartrate18%Bisoprolol Fumarate9%Part D<11 patientsStatin10.8%Atorvastatin Calcium60%Rosuvastatin Calcium40%Part D<11 patients+ 9 more classes in this area
Metabolism & gastrointestinal
4.5%SGLT2 inhibitor4.5%Jardiance100%Part D<11 patientsAnti-infectives
1.8%Penicillins with extended spectrum1.8%Amoxicillin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2009–2010 per NIH RePORTER. The latest:
- Inflammation and Atherosclerosis in Rheumatoid Arthritis
University of California, San Francisco
FY2010$62,186F32HL097461 - Inflammation and Atherosclerosis in Rheumatoid Arthritis
University of California, San Francisco
FY2009$59,810F32HL097461
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical Characteristics, Early GDMT Initiation, and Likelihood of Heart Failure With Improved Ejection Fraction
Journal of Cardiac Failure
2025 - 1-Year Outcomes After Transcatheter Edge-to-Edge Repair in Degenerative MR Stratified by Extent of Cardiac Damage
JACC: Cardiovascular Interventions
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Louis Fehrenbacher, MD
Kaiser Permanente
Susy Peng, MD
Kaiser Permanente
Prasanth Manthena, MD
Kaiser Permanente
Alan Go, MD
Kaiser Permanente
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”